Legend Biotech’s Post

𝐄𝐧𝐡𝐚𝐧𝐜𝐞 𝐘𝐨𝐮𝐫 𝐂𝐞𝐥𝐥 𝐒𝐞𝐩𝐚𝐫𝐚𝐭𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐂𝐞𝐥𝐥𝐓𝐫𝐢𝐜𝐬® 🧬 We’re thrilled to introduce 𝐂𝐞𝐥𝐥𝐓𝐫𝐢𝐜𝐬® – our cutting-edge cell strainers, designed for efficient and cost-effective cell separation. Whether you’re dealing with challenging workflows or aiming to optimize your lab’s performance, CellTrics® offers the solution you need. 𝐖𝐡𝐲 𝐂𝐡𝐨𝐨𝐬𝐞 𝐂𝐞𝐥𝐥𝐓𝐫𝐢𝐜𝐬®? 🚀 𝐌𝐢𝐧𝐢𝐦𝐢𝐳𝐞𝐝 𝐂𝐞𝐥𝐥 𝐃𝐚𝐦𝐚𝐠𝐞: Our patented technology ensures your cells remain intact, even at high flow rates. 🧩 𝐒𝐞𝐚𝐦𝐥𝐞𝐬𝐬 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐨𝐧: Easy-to-use and perfectly suited for your daily workflow. 💡 𝐔𝐧𝐫𝐢𝐯𝐚𝐥𝐥𝐞𝐝 𝐏𝐫𝐢𝐜𝐞-𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞: Superior performance without breaking the budget. If cell separation is a challenge in your lab, it’s time to make the switch to 𝐂𝐞𝐥𝐥𝐓𝐫𝐢𝐜𝐬®. #CellSeparation #LabInnovation #CellTrics #Biotech #LaboratoryExcellence #LifeSciences

Are you wondering how you are going to get from today to the clinic on someone else's crazy schedule? Luminyst can help. Learn more at luminyst.com #productdevelopment #lifesciences #biotech #efficiency #productlifecyclemanagement

📈 How is the bioplastics industry evolving? 📅 Tomorrow, 5 March 2024, Carmen Sanchez, CEO at ADBioplastics, will participate as a speaker at the 4th Annual Bioplastics Innovation Forum, organised by InventU and held in Munich, Germany. 💡 Our CEO will participate in session II, focused on how to accelerate the uptake of #bioplastics. Specifically, Carmen Sanchez will be present in a panel discussion on the opportunities and challenges of moving from the traditional #plastics industry to the #biobased plastics industry. 🗨 Other expert entities such as Emnandi Bioplastics, Biorepack, GO!PHA and Novamont will participate in this panel discussion. 📝 Do you want to know more? Find out how we are revolutionising the bioplastics industry 👉 https://lnkd.in/d9j_igJp

AMSilk GmbH | Biotech Materials is pleased to share that an independent Cradle-to-Gate Life Cycle Assessment (LCA) has shown AMSilk’s Ultrafine Fiber boasts a significantly lower environmental footprint compared to traditional mulberry silk! 🌍 Our spider silk-based biomaterials not only offer the potential for superior performance but also pave the way for a more sustainable future. These results, verified by Quantis, underscore our commitment to reducing environmental impacts through innovative, biofabricated solutions. For more information, read the full press release in the comments. #AMSilk #spidersilk #biofabricatedmaterials #Sustainability #Biomaterials

To all of my BioTech contacts out there.. here's how Fujifilm DB can help with the efficiency of your microbial manufacturing.

Time and material constraints can be an obstacle to rapid formulation development. Serán BioScience is technology agnostic and seeks to identify the best formulation strategy for your individual program, quickly and with minimal material. Learn more https://hubs.li/Q02h7-DX0 #drugdevelopment

EV Biotech is excited to announce our new collaboration with Synonym   EV Biotech’s unique platform utilizes computational prediction and qualitative lab-based confirmation to design and optimize microbial strains for the production of novel biomaterials. This collaboration will allow EV Biotech’s customers to access Synonym's biomanufacturing platform to accelerate scale-up and commercialization efforts, while Synonym’s customers will be able to leverage EV Biotech’s technology to minimize strain engineering costs, decrease time to market, and improve R&D outcomes.   “For bioproducts to seamlessly integrate into our daily lives, precision is essential for companies right from the initial stages of strain development. EV Biotech's state-of-the-art computational design technology empowers companies to enhance strain performance, effectively reducing their R&D time by half and accelerating their time to market,” said Joshua Lachter, Synonym's Co-Founder and Chief Business Officer.   "Synonym’s expertise in techno-economic analysis, lifecycle assessment, and facility development and financing will help our customers commercialize faster, cheaper, and more sustainably. We are excited to help more companies scale up successfully by identifying their commercial bioprocess milestones through Synonym’s platform and helping them reach their strain and fermentation targets using ours," added Linda Dijkshoorn, Chief Commercial Officer (CCO) and Founder of EV Biotech. If you're interested in better understanding essential milestones to improve future commercial viability of your bioprocess, please get in touch! [email protected] #fermentation #synbio #biotechnology #partnership

Exciting News from Prolific Machines! Baruch Future Ventures is thrilled to share that our portfolio company, Prolific Machines, announced their Series B/tech debut on June 6, 2024. Prolific Machines is revolutionizing biotechnology with their groundbreaking use of light. This innovative platform provides unprecedented control over cellular behavior, making the production of food, lifesaving drugs, and novel biosolutions more efficient and sustainable. What excites us most about Prolific’s technology is its ability to deliver direct and dynamic control over virtually any cellular function in any cell type. This game-changing innovation enhances efficiency, quality, reproducibility, and sustainability—paving the way for the future of biotechnology. Are you in the cellular agriculture, food, or pharma industries? Join Prolific Machines in co-developing the future of biology! Learn more about this revolutionary technology at prolific-machines.com. #ProlificMachines #Biotechnology #Innovation #CellularAgriculture #Pharmaceuticals #Sustainability Prolific Machines, Inc. Deniz Kent, PhD Max Huisman Declan Jones

Co2 Incubator Market Size, Share & Trends Analysis Report By Type (Water Jacketed carbon dioxide Incubators, Direct Heat carbon dioxide Incubators, Air Jacketed carbon dioxide Incubators), By Application (In Vitro Fertilization, Laboratory Research and Clinical Applications Laboratory Research and Clinical Applications, Other Applications), By End User (Research laboratories, Hospitals, Diagnostic centers, Others), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031. IMIR Market Research Pvt. Ltd. Don't miss out on this opportunity to stay informed about the latest trends in the Industry.   📚𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐏𝐫𝐢𝐜𝐞:📝👇https://lnkd.in/d_iX9qrR 📚𝐑𝐞𝐩𝐨𝐫𝐭 𝐅𝐨𝐜𝐮𝐬𝐞𝐝 𝐎𝐧 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: AIB Life Science Private Limited ALT | American Laboratory Trading Bellco Glass, Inc BINDER GmbH Blue Ocean Robotics BMT USA, LLC Cardinal Health Carnot Laboratorios Caron Group Cellbox Solutions CSK Scientific Eppendorf Group Esco Esco Lifesciences GmbH Germany Heal Force Labocon Systems Limited LEEC Limited Shanghai Electric Group Co., Ltd BoxUnion MarathonLS MEDISPEC Memmert GmbH + Co. KG N-BIOTEK Panasonic PHC Biomed PHC Holdings Corporation PTRC RADOBIO SCIENTIFIC CO.,LTD Sartorius Scigenics Biotech Pvt Ltd Sheldon Manufacturing, Inc. Thermo Fisher Scientific VWR, part of Avantor #Co2Incubator #Co2 #Carbon Dioxide #Incubator #Intellectualmarketinsightresearch👤 #Marketresearchreports #Size  #Share #Trends #Growth #Opportunity #Outlook #Forecast #Covid19 #Segments #KeyPlayers #RegionsOutlook #GrowthPotential #PriceTrends #CompetitiveMarket #Forecast 

In a recent survey, we asked: When it comes to transporting pharmaceuticals, what takes priority for you - cost optimization, quality, and performance, or sustainability? 73% of respondents indicated that ensuring the optimal condition of life-saving medications through the quality and performance of the solution is most important. However, with SkyCell, there's no need to prioritize; you can have it all. Here is how: ➡️ Cost Optimization: The 1500X has been engineered to be more efficient than other containers on the market. Four containers can be securely placed on one PMC, and 18 containers can be loaded into a standard truck. With its 379kg tare weight, the 1500X is the lightest SkyCell container in our portfolio. By decreasing the overall weight of the container but increasing the payload space, the 1500X remains at the optimal size for efficient transportation, maximizing cost savings. ➡️ Quality and performance: The 1500X delivers 270 hours of independent runtime, providing crucial protection during critical moments. Advanced technological features, including the integration of graphene into our patented heat distribution system, elevate the recharge capability of the 1500X when placed in a cold room or within a reefer truck. These features guarantee prolonged protection for pharmaceutical products, exemplifying our proficiency in pushing the boundaries of intelligent design. ➡️ Sustainability: SkyCell promotes a circular approach to pharmaceutical transport by enhancing the reusability, repairability, and recyclability of hybrid containers. In this model, containers are leased, returned, and reused, extending their lifecycle and reducing environmental impact. Additionally, hybrid containers have been independently certified and demonstrated a remarkable 50% decrease in CO₂ emissions compared to conventional containers. SkyCell not only aligns with your priorities in pharmaceutical transport but goes beyond. With the 1500X, we've perfected the balance of cost optimization, quality, and sustainability. https://lnkd.in/et3MqwUH #HybridContainers #Innovation #SupplyChain #Pharmaceuticalindustry #coldchain